BioMarin (BMRN) gets added to William Blair's September Current Better Values list, saying its...
Wednesday, September 12, 2012, 3:13 PM ETBioMarin (BMRN) gets added to William Blair's September Current Better Values list, saying its pipeline is one of the best in the industry. The company specializes in developing treatments for rare diseases and has a minimum of five drugs due to report various phase results before the end of the year. The most important of which is its BMN-110 Phase 3 data for the treatment of MPS IVA, a rare disease in which patients are missing the enzyme called galactose.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles